These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5072367)

  • 41. Differences in splitting capacity of virus and V. cholerae neuraminidases on sialic acid type substrates.
    Drzeniek R
    Biochem Biophys Res Commun; 1967 Mar; 26(6):631-8. PubMed ID: 6030973
    [No Abstract]   [Full Text] [Related]  

  • 42. Kelp extracts as antiviral substances.
    Kathan RH
    Ann N Y Acad Sci; 1965 Jul; 130(1):390-7. PubMed ID: 5216630
    [No Abstract]   [Full Text] [Related]  

  • 43. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
    Chamni S; De-Eknamkul W
    Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A practical synthesis of zanamivir phosphonate congeners with potent anti-influenza activity.
    Shie JJ; Fang JM; Lai PT; Wen WH; Wang SY; Cheng YS; Tsai KC; Yang AS; Wong CH
    J Am Chem Soc; 2011 Nov; 133(44):17959-65. PubMed ID: 21942552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir.
    Buxton RC; Edwards B; Juo RR; Voyta JC; Tisdale M; Bethell RC
    Anal Biochem; 2000 May; 280(2):291-300. PubMed ID: 10790313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro anti-influenza virus activity of isoquinoline alkaloids from thalictrum species.
    Serkedjieva J; Velcheva M
    Planta Med; 2003 Feb; 69(2):153-4. PubMed ID: 12624821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pterocarpans and flavanones from Sophora flavescens displaying potent neuraminidase inhibition.
    Ryu YB; Curtis-Long MJ; Kim JH; Jeong SH; Yang MS; Lee KW; Lee WS; Park KH
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6046-9. PubMed ID: 18938076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A comparative study of the neuraminidase activity of 2 strains of influenza A2 type virus].
    Orlova NG; Mekhedov LN
    Vopr Virusol; 1970; 15(3):341-6. PubMed ID: 5472073
    [No Abstract]   [Full Text] [Related]  

  • 49. The effect of azo dyes on myxovirus neuraminidase and on virus multiplication.
    Becht H; Drzeniek R
    J Gen Virol; 1968 Mar; 2(2):261-8. PubMed ID: 5690185
    [No Abstract]   [Full Text] [Related]  

  • 50. Studies on the role of myxovirus neuraminidase in virus-cell receptors interaction by means of direct determination of sialic acid split from cells. I. Experiments on influenza virus-RBC cell system.
    Tsvetkova IV; Lipkind MA
    Arch Gesamte Virusforsch; 1968; 23(4):299-312. PubMed ID: 4971430
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of heat treatment on influenza virus neuraminidase activity].
    Isaeva ES; Stetsenko OG; Kim EV; Sokolov MI
    Vopr Virusol; 1974; (6):670-4. PubMed ID: 4446565
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of physicochemical factors on influenza virus neuraminidase].
    Nekliudova LI; Orlova NG; Makarova GI
    Vopr Virusol; 1973; 18(3):338-41. PubMed ID: 4769538
    [No Abstract]   [Full Text] [Related]  

  • 53. Studies on the inhibitory effect of concanavalin A on the neuraminidase activity of influenza A virus strains.
    Zalan E; Wilson C; Freitag R; Labzoffsky NA
    Intervirology; 1974; 2(4):266-9. PubMed ID: 4854486
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparative enzyme kinetics of influenza neuraminidases with the synthetic substrate methoxyphenylneuraminic acid.
    Sedmak JJ; Grossberg SE
    Virology; 1973 Dec; 56(2):658-61. PubMed ID: 4757702
    [No Abstract]   [Full Text] [Related]  

  • 55. The sialic acids of horse serum with special reference to their virus inhibitory properties.
    Pepper DS
    Biochim Biophys Acta; 1968 Mar; 156(2):317-26. PubMed ID: 5689247
    [No Abstract]   [Full Text] [Related]  

  • 56. [Relationship between toxicity of influenza A2 virus strains, their sensitivity to inhibitors and enzymatic activity].
    Koveza TN; Gorbunova AS
    Vopr Virusol; 1972; 17(1):115-7. PubMed ID: 5013476
    [No Abstract]   [Full Text] [Related]  

  • 57. [Agglutinated activity bioassay method for the determination of antivirus potency of Banlangen granula].
    Tang HY; Yan D; Zhang SF; Li HB; Liu RH; Xiao XH
    Yao Xue Xue Bao; 2010 Apr; 45(4):479-83. PubMed ID: 21355214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The binding of exogenously added neuraminidase to cells and tissues in culture.
    McQuiddy P; Lilien JE
    Biochim Biophys Acta; 1973 Feb; 291(3):774-9. PubMed ID: 4735233
    [No Abstract]   [Full Text] [Related]  

  • 59. Synthesis of biologically active acycloAZT derivatives and related compounds.
    Murata M; Achiwa K
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):836-8. PubMed ID: 2347030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical properties of paramyxovirus Duck/Mississippi/75 neuraminidase.
    Kessler N; Aymard M
    J Gen Virol; 1979 Dec; 45(3):745-9. PubMed ID: 94350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.